首页> 美国卫生研究院文献>other >Why Did I Stop? Barriers and Facilitators to Uptake and Adherence to ART in Option B+ HIV Care in Lilongwe Malawi
【2h】

Why Did I Stop? Barriers and Facilitators to Uptake and Adherence to ART in Option B+ HIV Care in Lilongwe Malawi

机译:我为什么停下来?马拉维利隆圭的选项B + HIV护理中接受和坚持抗病毒治疗的障碍和促进者

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Causes for loss-to-follow-up, including early refusals of and stopping antiretroviral therapy (ART), in Malawi’s Option B+ program are poorly understood. This study examines the main barriers and facilitators to uptake and adherence to ART under Option B+. In depth interviews were conducted with HIV-infected women who were pregnant or postpartum in Lilongwe, Malawi (N = 65). Study participants included women who refused ART initiation (N = 10), initiated ART and then stopped (N = 26), and those who initiated ART and remained on treatment (N = 29). The barriers to ART initiation were varied and included concerns about partner support, feeling healthy, and needing time to think. The main reasons for stopping ART included side effects and lack of partner support. A substantial number of women started ART after initially refusing or stopping ART. There were several facilitators for re-starting ART, including encouragement from community health workers, side effects subsiding, decline in health, change in partner, and fear of future sickness. Amongst those who remained on ART, desire to prevent transmission and improve health were the most influential facilitators. Reasons for refusing and stopping ART were varied. ART-related side effects and feeling healthy were common barriers to ART initiation and adherence. Providing consistent pre-ART counseling, early support for patients experiencing side effects, and targeted efforts to bring women who stop treatment back into care may improve long term health outcomes.
机译:在马拉维的Option B +计划中,导致跟进失败的原因(包括及早拒绝和停止抗逆转录病毒疗法(ART))的了解甚少。这项研究探讨了在选项B +下吸收和坚持抗逆转录病毒疗法的主要障碍和促进因素。在马拉维利隆圭,对孕妇或产后感染了艾滋病毒的妇女进行了深入访谈(N = 65)。研究对象包括拒绝接受抗逆转录病毒治疗的妇女(N = 10),接受抗逆转录病毒治疗然后停止的妇女(N = 26)以及接受抗病毒治疗并继续接受治疗的妇女(N = 29)。开展抗逆转录病毒疗法的障碍各不相同,其中包括对伴侣支持,感觉健康以及需要时间思考的担忧。停止接受抗逆转录病毒治疗的主要原因包括副作用和缺乏合作伙伴的支持。最初拒绝或终止抗逆转录病毒治疗后,大量妇女开始抗逆转录病毒治疗。重新启动抗逆转录病毒疗法有几种促进因素,包括社区卫生工作者的鼓励,副作用的减轻,健康状况的下降,伴侣的改变以及对未来疾病的恐惧。在那些仍接受抗逆转录病毒疗法的人群中,预防传播和改善健康的愿望是最有影响力的促进者。拒绝和停止抗逆转录病毒疗法的原因多种多样。与ART相关的副作用和健康感觉是ART开始和坚持的常见障碍。提供一致的抗逆转录病毒治疗前咨询,对出现副作用的患者进行早期支持以及有针对性的努力使停止治疗的妇女重返护理领域,可能会改善长期健康状况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号